Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She joined The Christie in 2008 specialising in urology and sarcoma and has a strong interest in translational research. In 2013, she decided to focus on radiotherapy-related research in prostate and bladder cancers. She is clinical lead for advanced radiotherapy including the MRLinac project and is co-Group Leader of The Translational Radiobiology Group within the Division of Cancer Sciences. Professor Choudhury currently undertakes research which aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side effects and predictive biomarkers to determine which patients benefit from different treatments.

Professor Choudhury graduated from Trinity College, Cambridge, but undertook her Clinical Oncology training at the Yorkshire Deanery from 2000-2008. Between 2005 and 2007, she was a Cancer Research UK Clinical Training Research Fellow and she undertook her PhD at the University of Leeds and Princess Margaret Hospital in Toronto, Canada. For her PhD she studied the molecular epidemiology of DNA double strand break repair in bladder cancer and the use of systemic agents for enhanced chemosensitivity and radiosensitivity. She has a lead role in education and training for specialist registrars and clinical fellows.

Professor Choudhury is a member of a member of work stream 2 of the National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Research Working Group (CTRad) and of the NCRI Bladder Clinical Studies Group. She has also been a member of the NICE bladder cancer guideline development group. Professor Choudhury is the Senior Editor for Genito-urinary cancers for the International Journal of Radiation Oncology • Biology • Physics (The Red Journal).

2008                  PhD

2004                  F.R.C.R

2000                  MRCP

1997                  MA (Cantab)

1995                  MB. BChir (Cantab)

1993                  BA (Hons)

2016                  Global Bladder Cancer Congress – International Organising Committee

2016                  RCR Academic Committee

2016                  ASTRO Representative for GU ASCO and Faculty

2015                  ASTRO Abstract Committee and Faculty

2015                  NICE Bladder Cancer Quality Standards Committee

2014                  Associate Senior Editor, Int J Radiat Oncol Biol Phys

2013 – 2016     Royal College of Radiologists Speciality Training Board – Academic Lead

2012 – 2015     NICE Bladder Cancer Guideline Development Group

2011                  NCRI Bladder Clinical Studies Group

2009                  CTRad Workstream II: Phase I/II Radiotherapy Studies

2008                  Christie Radiation-related Research Group

Peter Hoskin

Catharine West

Corinne Faivre-Finn

Gillian Whitfield

Marcel van Herk

Alan McWilliam

Philip Whitehurst

Marianne Aznar

2019                       FRCR Clinical Oncology Examination Board, RCR

2018-2019             Teaching on the Higher Specialist Scientists Training (HSST), Clinical Applications of Medical Imaging Technologies, University of Manchester

2018-2019             Teaching on The Christie FRCR Biological Basis of Cancer Therapy Course

2017                       ASTRO Global Health Initiative Rotation Director

2015-2016              MRes Oncology, Clinical Radiosensitisation Tutorial, University of Manchester

2014                       Academic Clinical Lead for Speciality Training Board, RCR

2014                       Lead for Academic Clinical Fellows in Clinical Oncology, Manchester

2012                       Interviewer for National Recruitment for Clinical Oncology

2012                       Clinical Oncology National Recruitment Steering Committee

2012-2015              RCR College Tutor

2014                       Faculty for The Christie FRCR IIb Course

2012-2015              Co-ordinator of FRCR ptII Clinical OSCE teaching and lecture course

2009                       Clinical Supervisor for Uro-Oncology and Sarcoma

2009                       Educational Supervisor for Clinical Oncology trainees, including Academic Clinical Fellows and Clinical Research Fellows

2005                       General Part I/II FRCR Teaching

Clinical lead for technical radiotherapy; member of the Radiation-Related Research group; member of the Christie Urological Disease orientated Group; Urology Radiotherapy Research lead; Clinical project lead for MR Linac; RCR College Tutor; Academic Clinical Fellow lead for Clinical Oncology.

Urology radiotherapy lead for The Christie at Oldham; Member of National CTRad (Radiotherapy Research Group) Workstream II: phaseI/II radiotherapy-related studies; Member of National Bladder Cancer Clinical Studies Group; NICE Bladder Cancer Guideline Development Group.

McPartlin, Andrew. MD. Use of magnetic resonance imaging in radical prostate radiotherapy. 2016.

Dania Satiti, Amanda. MRes. Outcome comparison of radical cystectomy and bladder preservation approaches in non-metastatic muscle invasive bladder cancer. 2019.

Corden, Michael. APEP. The role of sarcopenia in determining prognosis of bladder cancer patients with radiotherapy. 2019.

Forker, Laura. PhD. Development of a hypoxia biomarker for soft tissue sarcoma. 2020.

Tharmalingam, Hannah. MD. Optimizing the radiotherapy management of high-risk prostate cancer patients. 2020.

Song, Yee Pei. MD. MR imaging in bladder cancer. 2020.

Thiruthaneeswaran, Niluja. PhD. Translating companion hypoxia response-predictive biomarkers into clinical practice in prostate cancer. 2020.

Cree, Anthea. PhD. MR guided external beam radiotherapy for cervical cancer. 2020.

Walshaw, Richard. PhD. Investigating immunomodulation to improve outcome in bladder cancer. 2020.

Guerrero Quiles, Conrado. PhD. Proteomic profiling in cancer patients undergoing radiotherapy. Expected 2021.

Rodrigues Pereira, Ronnie. PhD. Machine learning approaches to improve the treatment of prostate cancer. Expected 2021.

Shabbir, Rekaya. PhD. Expected 2021.

Datta, Anubhav. PhD. Evaluation of biomarkers for clinical hypoxia modification in cervical cancer. Expected 2022.

Hussain, Abdulaziz. PhD. Developing a pipeline for reliable, agile production of radiopharmaceuticals. Expected 2023.

Daly, Mairead. PhD. Evaluation of motion management strategies across multiple radiotherapy platforms. Expected 2024.